Surgical Outcomes After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer

BACKGROUND: Neoadjuvant chemoimmunotherapy for resectable non-small cell lung cancer (NSCLC) represents an important research topic. Despite the potential benefits of this approach, the inflammatory responses and adverse events associated with neoadjuvant chemoimmunotherapy can present technical cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yan, Ren, Si-Ying, Wang, Ruo-Yao, Zeng, Chao, Li, Ji-Na, Xiao, Peng, Wu, Fang, Yu, Feng-Lei, Liu, Wen-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526888/
https://www.ncbi.nlm.nih.gov/pubmed/34692476
http://dx.doi.org/10.3389/fonc.2021.684070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526888/
https://www.ncbi.nlm.nih.gov/pubmed/34692476
http://dx.doi.org/10.3389/fonc.2021.684070

Ejemplares similares